Preimplantation Genetic Testing in Women of Advanced Maternal Age

Not Recruiting

Trial ID: NCT04167748


The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

Official Title

GEnetic Testing in Elective Single Embryo Transfer in Women of Advanced Maternal Age

Stanford Investigator(s)

Ruth Lathi, M.D.
Ruth Lathi, M.D.

Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility)


Inclusion Criteria:

   - Women undergoing IVF of between 35 and 40 years of age at IVF cycle start

   - Utilization of Intracytoplasmic Sperm Injection ICSI

   - Utilization of ejaculated or testicular sperm

   - Utilization of autologous or donor sperm

   - All Controlled Ovarian Hyperstimulation (COH) protocols

Exclusion criteria:

   - Patients with anovulatory Polycystic ovarian syndrome (PCOS)

   - Utilization of donor oocytes

   - Utilization of gestational carrier

   - Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages

   - Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers


procedure: Preimplantation genetic testing for aneuploidy (PGT-A)

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Ruth B Lathi, MD